These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9651001)

  • 1. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin.
    Aarestrup FM
    Microb Drug Resist; 1998; 4(2):137-41. PubMed ID: 9651001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the use of avilamycin for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers: epidemiological study and changes over time.
    Aarestrup FM; Bager F; Andersen JS
    Microb Drug Resist; 2000; 6(1):71-5. PubMed ID: 10868810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark.
    Aarestrup FM; Seyfarth AM; Emborg HD; Pedersen K; Hendriksen RS; Bager F
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2054-9. PubMed ID: 11408222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway.
    Aarestrup FM; Kruse H; Tast E; Hammerum AM; Jensen LB
    Microb Drug Resist; 2000; 6(1):63-70. PubMed ID: 10868809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark.
    Aarestrup FM; Agerso Y; Gerner-Smidt P; Madsen M; Jensen LB
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):127-37. PubMed ID: 10863107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of avilamycin for growth promotion and avilamycin-resistance among Enterococcus faecium from broilers in a matched case-control study in France.
    Chauvin C; Gicquel-Bruneau M; Perrin-Guyomard A; Humbert F; Salvat G; Guillemot D; Sanders P
    Prev Vet Med; 2005 Sep; 70(3-4):155-63. PubMed ID: 16023523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity.
    Nakashio S; Iwasawa H; Dun FY; Kanemitsu K; Shimada J
    Drugs Exp Clin Res; 1995; 21(1):7-16. PubMed ID: 7796712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of enterococci recovered from commercial swine carcasses: effect of feed additives.
    Davies R; Roberts TA
    Lett Appl Microbiol; 1999 Nov; 29(5):327-33. PubMed ID: 10664974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The susceptibility to growth-promoting antibiotics of Enterococcus faecium isolates from pigs and chickens in Europe.
    Bywater R; McConville M; Phillips I; Shryock T
    J Antimicrob Chemother; 2005 Sep; 56(3):538-43. PubMed ID: 16085669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of avilamycin fed to chickens on E. faecium counts and on the selection of avilamycin-resistant E. faecium populations.
    Butaye P; Devriese LA; Haesebrouck F
    Microb Drug Resist; 2005; 11(2):170-7. PubMed ID: 15910233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by Etest.
    Terakubo S; Takemura H; Yamamoto H; Ikejima H; Kunishima H; Kanemitsu K; Kaku M; Shimada J
    J Infect Chemother; 2001 Dec; 7(4):263-6. PubMed ID: 11810596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the growth promoter avilamycin on emergence and persistence of antimicrobial resistance in enteric bacteria in the pig.
    Delsol AA; Randall L; Cooles S; Woodward MJ; Sunderland J; Roe JM
    J Appl Microbiol; 2005; 98(3):564-71. PubMed ID: 15715858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin).
    Aarestrup FM; Jensen LB
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3425-7. PubMed ID: 11083650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; WiechuĊ‚a B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis on antibiotic resistance characteristics of Listeria spp. and Enterococcus spp. isolated from laying hens and eggs in conventional and organic keeping systems in Bavaria, Germany.
    Schwaiger K; Schmied EM; Bauer J
    Zoonoses Public Health; 2010 May; 57(3):171-80. PubMed ID: 19486494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of high-level evernimicin resistance in Enterococcus faecium among food animals and humans.
    Aarestrup FM; McNicholas PM
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3088-90. PubMed ID: 12183279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of avilamycin administration and its subsequent withdrawal on emergence and disappearance of antimicrobial resistance in enterococci in the intestine of broiler chickens.
    Katsunuma Y; Hanazumi M; Fujisaki H; Minato H; Hashimoto Y; Yonemochi C
    J Appl Microbiol; 2007 Apr; 102(4):1159-66. PubMed ID: 17381760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species distribution and resistance patterns to growth-promoting antimicrobials of enterococci isolated from pigs and chickens in Korea.
    Hwang IY; Ku HO; Lim SK; Park CK; Jung GS; Jung SC; Nam HM
    J Vet Diagn Invest; 2009 Nov; 21(6):858-62. PubMed ID: 19901290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug resistance of 100 clinical strains of Enterococcus spp].
    Sawicka-Grzelak A; Rokosz A; Luczak M
    Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility to everninomycin of gram-positive nosocomial pathogens isolated from intensive care units in Germany.
    Kropec A; Frank U; Jonas D; Thriene W; Schmidt-Eisenlohr E; Daschner FD
    Chemotherapy; 2001; 47(1):15-8. PubMed ID: 11125228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.